Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-07-01
1996-10-22
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 53, 514 2, 514 8, 536 41, 536 182, 536 187, 536 55, 536 553, A61K 3170, A61K 31715, A61K 3700, A61K 3710
Patent
active
055676839
ABSTRACT:
Simple lactose or lactosamine related compounds which behave as ligands for the ELAM-1 and related receptors are described. These compounds are useful in the treatment of conditions characterized by excess inflammation. These compounds are of the formula ##STR1## wherein each R.sup.1 is independently H or lower alkyl (1-4C); R.sup.2 is H, lower alkyl (1-4C), alkylaryl or one or more additional saccharide residues;
REFERENCES:
patent: 4661345 (1987-04-01), Tuomanen
patent: 4994441 (1991-02-01), Neeser
EPO Supplementary Search Report for EP Application No. 929252529.1.
Berg, Ellen L. et al., A Carbohydrate Domain Common to Both Sialyl Le.sup.a and Sialyl Le.sup.x is Recognized by the Endothelial Cell Leukocyte Adhesion Molecule ELAM-1, Journal of Biol. Chem., vol. 266, No. 23, pp. 14869-4872 (1991).
Nicolaou, K. C., et al. Stereocontrolled Synthesis of Sialyl Le.sup.x, the Oligosaccharide Binding Ligand to ElAM-1 (Sialyl=N-acetylneuramin), J. Chem. Soc., Chem. Commun., pp. 870-872 (1991).
Nillson, Marianne et al., Synthesis of Carbohydrate Derivatives Corresponding to a Tumor-Associated Glycolipid: A Trimeric Lewis X Nonasaccharide and a Trimeric N-Acetyl Lactosamine Hexasaccharide, J. Carbohydrate Chemistry, pp. 613-627 (1989).
Stanley, Pamela et al., The LEC11 Chinese Hamster Ovary Mutant Synthesizes N-Linked Carbohydrates Containing Sialylated, Fucosylated Lactosamine Units, Journal of Biological Chemistry, vol. 263, No. 23, pp. 11374-11381 (1988).
Tiemeyer, Michael et al., Carbohydrate Ligands for Endothelial-Leukocyte Adhesion Molecule 1, Proc. Natl. Acad. Sci. USA, vol. 88, pp. 1138-1142 (1991).
Tyrrell, David et al., Structural Requirements for the Carbohydrate Ligand of E-Selectin. Proc. Natl. Acad. Sci. USA, vol. 88, pp. 10372-10376 (1991).
Gundel, et al., J. Clin. Invest. 88:1407-1411, 1991.
Mulligen, et al., Nature, 364:149-149-151, 1993.
Mulligen, et al., J. Clin. Invest. 90:1600-1607, 1992.
Ladisch, et al., J. Clin Invest. 74:2074-2081, 1984.
Khara, et al., Comb. Res. 136:285-308, 1985.
Keilical, et al., Carb. Res. 40:255-262, 1975.
Berg, et al., J. Biol. Chem. 266(23):14869-14872.
Kitagana, et al., B.B.R.C. 178(3):1429-1436, 1991.
Takada, et al. B.B.R.C. 179(2):713-719, 1991.
Hakomori, et al, B.B.R.C. 100(4) 1578-86, 1981.
Gooi, et al., Nature 292:156-8, 1981.
Shur, J. Biol. Chem. 257(12):6871-8, 1982.
Bird, et al., Devel. Biol. 104:449-460, 1984.
Fenderson, et al., J. Exp. Med. 160:1591-1596, 1984.
Gabius, et al., Anticancer Res, 6:573-851 1986.
Lis et al., Ana. Rev. Biochem. 55:35-67, 1986.
Sato, et al., Carb. Res. 155:C6-C10, 1986.
Fenderson, et al., Devel. Biol. 122:21-34, 1987.
Dasgupta, et al., Carb. Res 177:C13-C17, 1988.
Fenderson, et al Differentiation 38:124-133, 1988.
Kojima, et al., J. Biol. Chem. 264(34):20159-62, 1989.
Eggens, et al., J. Biol. Chem. 264(16):9476-84, 1989.
Gundel et al., "Endothelial Leukocyte Adhesion Molecule-1 Mediates Antigen-induced Acute Airway Inflammation and Late-phase Airway Obstruction in Monkeys," J. Clin. Invest. 88:1407-1411 (1991).
Mulligan et al., "Protective Effect is of Oligosaccharides in P-Selectin.gtoreq.Dependent Lung Injury," Nature, 364:149-151 (1993).
Mulligan et al., "Neutrophil-dependent Acute Lung Injury," J. Clin. Invest. 90:1600-1607 (992).
Hakomori et al., "The Hapten Structure of a developmentally regulated Glycolipid Antigen (SSEA-1) isolated from human erythrocytes and Adenocarcinoma," Biochem. Biophys. Res. Commun. 100(4):1578-86 (1981).
Gooi et al., "Stage-specific embryonic antigen involves .alpha.1.fwdarw.3 fucosylated type 2 blood group chains," Nature 292:156-158 (1981).
Bird et al., "Oligosaccharides Containing Fucose Linked .alpha.(1-3) and .alpha.(1-4) to N-Acetylglucosamine Cause Decompaction of Mouse Morulae," Biol. 104:449-60 (1984).
Sato et al., "An efficient approach to O-glycosides through CuBr.sub.2 --Bu.sub.4 NBr mediated activation of glycosides," Carb. Res. 155:C6-C10 (1986).
Fenderson et al., "The blood group I antigen defined by monoclonal antibody C6 is a marker of early mesoderm during murine embryogenesis," Differentiation 38:124-133 (1988).
Kojima et al., "Specific Interaction between Gangliotriaosylceramide Gg.sub.3) and Sialosyllactosylceramide (G.sub.m3) as a Basis for Specific Cellular Recognition between Lymphoma and Melanoma Cells", J. Biol. Chem. 284(34):20159-62 (1989).
Eggens et al., "Specific Interaction between Le.sup.x and Le.sup.x Determinants," J. Biol. Chem. 264(16):9476-84 (1989).
Ladisch et al., "Modulation of the Immune response by gangliosides," J. Clin. Invest. 74:2074-2081 (1984).
Cavillon et al., "Inhibition of lipopolysaccharide-induced monocyte interleukin 1 secretion by gangliosides," European Journl. of Immunol. 16:1009-1012 (1986).
Khare et al., "The synthesis of monodeoxy derivatives of Lacto-N-biose 1 and N-acetyl-lactosamine to serve as substrates for the differentiation of alpha-L-fucosyl Transferase," Carbohydrate Res. 136:285-308 (1985).
Keilical et al., Carb. Res. 40:255-262 (1975).
Berg et al., J. Biol. Chem. 266(23)14869-14872 (8-1991).
Abbas Saeed A.
Asa Darwin S.
Dasgupta Falguni
Musser John H.
Nashed Mina A.
Glycomed Incorporated
Rollins John W.
LandOfFree
Substituted lactose and lactosamine derivatives as cell adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted lactose and lactosamine derivatives as cell adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted lactose and lactosamine derivatives as cell adhesion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358739